{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:13:58Z","timestamp":1788300838433,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128876","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T19:16:43Z","timestamp":1782501403000},"page":"128876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intranasal influenza vaccination using an outer membrane vesicle platform"],"prefix":"10.1016","volume":"89","author":[{"given":"Ann-Christin","family":"Magnusson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calle","family":"Niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van den Berg van Saparoea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128876_bb0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","author":"Taubenberger","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128876_bb0010","first-page":"69","article-title":"An analysis for the global burden of disease study 2017","volume":"20192018","author":"Troeger","year":"2017","journal-title":"The Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2026.128876_bb0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2026.128876_bb0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.15585\/mmwr.mm7432a2","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2025\u201326 influenza season","volume":"74","author":"Grohskopf","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128876_bb0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jiy633","article-title":"Influenza vaccines: good, but we can do better","volume":"219","author":"Paules","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128876_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","article-title":"Localized mucosal response to intranasal live attenuated influenza vaccine in adults","volume":"207","author":"Barr\u00eda","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128876_bb0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/21645515.2017.1377376","article-title":"Immune responses after live attenuated influenza vaccination","volume":"14","author":"Mohn","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128876_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/pds.4349","article-title":"The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a vaccine safety datalink study","volume":"27","author":"Daley","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2026.128876_bb0045","first-page":"33","article-title":"Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review","author":"Prutsky","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128876_bb0050","first-page":"62","article-title":"The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness","author":"Ashraf","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128876_bb0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"Rose","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128876_bb0060","first-page":"14","article-title":"Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine","author":"Thwaites","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128876_bb0065","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.vaccine.2008.03.055","article-title":"A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs","volume":"26","author":"Quan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128876_bb0070","article-title":"Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses","volume":"13","author":"Lee","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128876_bb0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2024998118","article-title":"Intranasal vaccination with influenza HA\/GO-PEI nanoparticles provides immune protection against homo- and heterologous strains","volume":"118","author":"Dong","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.128876_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12951-025-03122-6","article-title":"Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine","volume":"23","author":"Zhao","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.vaccine.2026.128876_bb0085","first-page":"5","article-title":"Bacterial outer membrane vesicles and vaccine applications","author":"Acevedo","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128876_bb0090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/pharmaceutics13020131","article-title":"Bacterial-derived outer membrane vesicles are potent adjuvants that drive humoral and cellular immune responses","volume":"13","author":"Prior","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2026.128876_bb0095","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2026.128876_bb0100","first-page":"20","article-title":"Catching a SPY: using the SpyCatcher-SpyTag and related systems for labeling and localizing bacterial proteins","author":"Hatlem","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2026.128876_bb0105","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.128876_bb0110","article-title":"Display of recombinant proteins on bacterial outer membrane vesicles by using protein ligation","volume":"84","author":"Saparoea","year":"2018","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2026.128876_bb0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"Nalt-versus Peyer\u2019s-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128876_bb0120","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.vaccine.2004.11.032","article-title":"Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG","volume":"23","author":"Rodr\u00edguez","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128876_bb0125","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128876_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1745319","article-title":"Intranasal vaccines adjuvanted with Nexavant demonstrate robust protective efficacy by inducing both mucosal and systemic immunity in a murine model","volume":"16","author":"Ko","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128876_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41541-026-01430-y","article-title":"Tracking spatio-temporal dynamics of early immune responses to an intranasal OMV-based pneumococcal vaccine candidate in mice","volume":"11","author":"Kanwal","year":"2026","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128876_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41541-025-01280-0","article-title":"Advances and prospects of respiratory mucosal vaccines: mechanisms, technologies, and clinical applications","volume":"10","author":"Li","year":"2025","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128876_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085582","article-title":"Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity","volume":"9","author":"Muramatsu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128876_bb0150","doi-asserted-by":"crossref","first-page":"e00408","DOI":"10.1128\/JVI.00408-20","article-title":"Potential role of nonneutralizing IgA antibodies in cross-protective immunity against influenza a viruses of multiple hemagglutinin subtypes","volume":"94","author":"Okuya","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128876_bb0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2422171122","article-title":"Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza a viruses in mice","volume":"122","author":"Moriyama","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.128876_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12192","article-title":"A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants","volume":"11","author":"Jiang","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.vaccine.2026.128876_bb0165","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:23:50Z","timestamp":1788297830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26006857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0264410X26006857"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128876","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal influenza vaccination using an outer membrane vesicle platform","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128876"}}